Center-Authored Papers

Filters: Author is Fisher, Richard  [Clear All Filters]
Journal Article
Cook JR, Goldman B, Tubbs RR, Rimsza L, LeBlanc M, Stiff P, Fisher R.  2014.  Clinical Significance of MYC Expression and/or "High-grade" Morphology in Non-Burkitt, Diffuse Aggressive B-cell Lymphomas: A SWOG S9704 Correlative Study.. The American journal of surgical pathology. 38(4):494-501. Abstract
Persky DO, Dornan D, Goldman B, Braziel R, Fisher R, LeBlanc M, Maloney DG, Press O, Miller T, Rimsza LM.  2012.  Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone.. Haematologica. 97(6):937-942. Abstract
Vose JM, Carter S, Burns LJ, Ayala E, Press OW, Moskowitz CH, Stadtmauer EA, Mineshi S, Ambinder R, Fenske T et al..  2013.  Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT C. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(13):1662-8. Abstract